Literature DB >> 2275937

Is thioridazine retinopathy progressive? Relationship of pigmentary changes to visual function.

M F Marmor1.   

Abstract

Thioridazine toxicity has been described as a 'progressive chorioretinopathy', but this designation can be misleading. During the first year after thioridazine exposure retinal pigmentation evolves from a granular to a patchy or nummular appearance. However, visual function and the electroretinogram typically improve during this period. Some cases may show chorioretinal atrophy and functional loss many years later, but there is little evidence for ongoing drug-related progression. Late atrophy may represent degeneration of cells that were injured subclinically at the time of initial drug exposure. Although thioridazine toxicity produces an evolving pigmentary disturbance, functional changes must be monitored independently of fundus appearance.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2275937      PMCID: PMC1042279          DOI: 10.1136/bjo.74.12.739

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  11 in total

1.  CHORIORETINOPATHY ASSOCIATED WITH THIORIDAZINE THERAPY.

Authors:  M M CONNELL; B J POLEY; J R MCFARLANE
Journal:  Arch Ophthalmol       Date:  1964-06

2.  The concentration of phenothiazines in the eye of experimental animals.

Authors:  A M POTTS
Journal:  Invest Ophthalmol       Date:  1962-08

3.  Thioridazine pigmentary retinopathy.

Authors:  F H Davidorf
Journal:  Arch Ophthalmol       Date:  1973-09

4.  Atrophic creep of the retinal pigment epithelium after focal macular photocoagulation.

Authors:  C M Morgan; H Schatz
Journal:  Ophthalmology       Date:  1989-01       Impact factor: 12.079

5.  Progression of retinopathy long after cessation of chloroquine therapy.

Authors:  S Ogawa; N Kurumatani; N Shibaike; S Yamazoe
Journal:  Lancet       Date:  1979-06-30       Impact factor: 79.321

6.  Nummular thioridazine retinopathy.

Authors:  D Kozy; B H Doft; J Lipkowitz
Journal:  Retina       Date:  1984 Fall-Winter       Impact factor: 4.256

7.  Drug-induced macular disease.

Authors:  A M Potts
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1966 Nov-Dec

8.  Progressive chorioretinopathy after receiving thioridazine.

Authors:  T A Meredith; T M Aaberg; W D Willerson
Journal:  Arch Ophthalmol       Date:  1978-07

9.  Long-term course of chloroquine retinopathy after cessation of medication.

Authors:  J R Brinkley; E L Dubois; S J Ryan
Journal:  Am J Ophthalmol       Date:  1979-07       Impact factor: 5.258

10.  Delayed-onset chloroquine retinopathy.

Authors:  M Ehrenfeld; R Nesher; S Merin
Journal:  Br J Ophthalmol       Date:  1986-04       Impact factor: 4.638

View more
  4 in total

Review 1.  Ocular adverse effects of neuropsychiatric agents. Incidence and management.

Authors:  T Oshika
Journal:  Drug Saf       Date:  1995-04       Impact factor: 5.606

2.  Aripiprazole-induced chorioretinopathy: multimodal imaging and electrophysiological features.

Authors:  Céline Faure; Isabelle Audo; Christina Zeitz; Jean-Bernard Letessier; Matthieu P Robert
Journal:  Doc Ophthalmol       Date:  2015-03-20       Impact factor: 2.379

3.  Pathogenesis of degenerative retinopathies induced by thioridazine and other antipsychotics: a dopamine hypothesis.

Authors:  Pantaleo Fornaro; Giovanni Calabria; Guido Corallo; Giovanni B Picotti
Journal:  Doc Ophthalmol       Date:  2002-07       Impact factor: 2.379

Review 4.  Wide field retinal imaging and the detection of drug associated retinal toxicity.

Authors:  Giulia Corradetti; Sara Violanti; Adrian Au; David Sarraf
Journal:  Int J Retina Vitreous       Date:  2019-12-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.